News & Updates

Post-ICH antiplatelet therapy not linked to recurrent ICH
Post-ICH antiplatelet therapy not linked to recurrent ICH
28 Oct 2021 byRoshini Claire Anthony

Initiating antiplatelet therapy following an intracerebral haemorrhage (ICH) that occurred during antithrombotic use does not lead to recurrent symptomatic ICH, according to extended results of the RESTART* trial.

Post-ICH antiplatelet therapy not linked to recurrent ICH
28 Oct 2021
Dietary ALA intake may lower risks of all-cause, CVD, CHD mortality
Dietary ALA intake may lower risks of all-cause, CVD, CHD mortality
28 Oct 2021 byStephen Padilla

Dietary intake of alpha linolenic acid (ALA) appears to reduce the risk of mortality from all causes, cardiovascular disease (CVD), and coronary heart disease (CHD) but may slightly increase the risk of cancer mortality, according to a systematic review and meta-analysis. Moreover, an association exists between higher blood levels of ALA and a lower risk of all-cause and CHD mortality.

Dietary ALA intake may lower risks of all-cause, CVD, CHD mortality
28 Oct 2021